文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

南非三省药物敏感结核患者中evriMED依从性监测联合差异化响应与标准治疗的整群随机对照试验方案

Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
PubMed 文献 · Trials · 2021-06-09

本研究在南非三个省的18家公共卫生诊所开展整群随机对照试验,计划纳入约2610例药物敏感结核患者。干预组使用Wisepill evriMED 1000药物监测器并基于依从性数据实施差异化关怀(短信提醒、电话、家访、动机咨询),对照组接受监测器追踪和标准治疗。主要结局为监测器测得依从性>80%的患者比例,并评估可行性、可接受性和成本效果。

要点

  • 干预组基于实时监测数据实施分级响应:漏服1次短信提醒,2-3次电话,≥4次家访,反复≥4次动机咨询。
  • 主要结局为药物监测器测得依从性>80%的患者比例,两组均使用监测器追踪。
  • 研究将评估干预的可行性、可接受性及成本效果,为结核依从性管理提供证据。

核心结论

  • 该试验旨在评估药物监测器联合差异化关怀对药物敏感结核患者依从性和治疗完成率的影响。

研究设计与样本

  • 整群随机对照试验,在南非三个省18家公共卫生诊所开展,诊所随机分为干预组或标准治疗组。
  • 每家诊所约纳入145例药物敏感结核患者,总样本量目标为2610例。

主要发现

  • 原文未报告结果数据。

关键数值与推荐

  • 主要结局为药物监测器测得依从性>80%的患者比例。
  • 干预组差异化关怀包括:漏服1次自动短信提醒,第2或第3次漏服由研究人员电话联系,漏服≥4次家访,反复漏服≥4次动机咨询。
  • 对照组接受药物监测器追踪、标准结核教育和常规诊所随访。

临床怎么用

  • 基于实时药物监测数据的差异化关怀策略可能改善结核治疗依从性和完成率。
  • 干预包含短信、电话、家访和动机咨询的分级响应,可供结核依从性管理参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: South Africa has achieved drug-susceptible TB (DS-TB) treatment success of only 77% among people with new and previously treated TB. Alternative approaches are required to improve medication adherence and treatment completion to limit transmission, TB relapse and the development of resistance. This study aims to implement and evaluate the use of adherence medication monitors (Wisepill evriMED 1000) with a differentiated response to patient care, among DS-TB patients in three provinces of South Africa. METHODS: In total, 18 public health clinics across three provinces were selected. Clinics were randomised to intervention or standard of care clinics. In each clinic, approximately 145 DS-TB patients are being enrolled to reach a total of 2610. All patients have their daily adherence monitored using medication monitors. In the intervention arm, patients are receiving medication monitor reminders and differentiated care in response to adherence data. This weekly review of daily real-time monitoring will be undertaken from a central database. The differentiated care model includes automated SMS reminders with a missed dose, research staff-initiated phone call to the patient with a second or third missed dose, a home visit if four or more doses are missed, and motivational counselling if four or more doses are missed repeatedly. Fidelity of the intervention will be measured through process evaluation. Patients in control clinics will receive medication monitors for adherence tracking, standard of care TB education, and normal clinic follow-up procedures. The primary outcome is the proportion of patients by arm with >80% adherence, as measured by the medication monitor. The feasibility and acceptability of the intervention will be assessed by in-depth interviews with patients, stakeholders, and study staff. A cost effectiveness analysis of the intervention and standard of care clinics will be conducted. SIGNIFICANCE: This trial will provide evidence for the use of an intervention, including medication monitors and differentiated care package, to improve adherence to TB treatment. Improved adherence should also improve TB treatment completion rates, thus reducing loss to follow-up rates, and TB relapse among people with TB. The intervention is intended to ultimately improve overall TB control and reduce TB transmission in South Africa. TRIAL REGISTRATION: Pan African Trial Registry PACTR201902681157721 . Registered on 11 February 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Maraba N, Orrell C, Chetty-Makkan CM, et al. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial. Trials. 2021. PMID: 34108036. doi:10.1186/s13063-021-05337-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。